SIOG (International Society of Geriatric Oncology) and anthracycline use in the elderly

Droz, 2008, Overcoming challenges associated with chemotherapy treatment in the senior adult population, Crit Rev Oncol Hematol, 68, S1, 10.1016/j.critrevonc.2008.07.005 Muss, 2007, Adjuvant treatment of elderly breast cancer patients, Breast, 16, S159, 10.1016/j.breast.2007.07.026 Aapro, 2010, Launching the Journal of Geriatric Oncology: a historical milestone, J Geriatric Oncol, 1, 2, 10.1016/j.jgo.2010.04.003 Fentiman, 1990, Cancer in the elderly: why so badly treated?, Lancet, 335, 1020, 10.1016/0140-6736(90)91075-L Extermann, 2005, Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG), Crit Rev Oncol Hematol, 55, 241, 10.1016/j.critrevonc.2005.06.003 Aapro, 2011, Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper, Ann Oncol, 22, 257, 10.1093/annonc/mdq609 Hutchins, 1999, Underrepresentation of patients 65 years of age or older in cancer-treatment trials, N Engl J Med, 341, 2061, 10.1056/NEJM199912303412706 Pallis, 2011, EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors, Ann Oncol, 10.1093/annonc/mdq687 NCCN Clinical Practice Guidelines in Oncology Monteserin, 2010, Effectiveness of a geriatric intervention in primary care: a randomized clinical trial, Fam Pract, 27, 239, 10.1093/fampra/cmp101 2008, Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials, Lancet, 371, 29, 10.1016/S0140-6736(08)60069-0 Colucci, 2004, Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN), Am J Cardiol, 93, 13B, 10.1016/j.amjcard.2004.01.018 Walter, 2001, Cancer screening in elderly patients: a framework for individualized decision making, JAMA, 285, 2750, 10.1001/jama.285.21.2750 Muss, 2009, Adjuvant chemotherapy in older women with early-stage breast cancer, N Engl J Med, 360, 2055, 10.1056/NEJMoa0810266 Muss, 2005, Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer, JAMA, 293, 1073, 10.1001/jama.293.9.1073 Singal, 1998, Doxorubicin-induced cardiomyopathy, N Engl J Med, 339, 900, 10.1056/NEJM199809243391307 Fromme, 2004, How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30, J Clin Oncol, 22, 3485, 10.1200/JCO.2004.03.025 Cardinale, 2004, Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy, Circulation, 109, 2749, 10.1161/01.CIR.0000130926.51766.CC Okumura, 2000, Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity, Acta Haematol, 104, 158, 10.1159/000046508 Belham, 2007, Monitoring left ventricular function in adults receiving anthracycline-containing chemotherapy, Eur J Heart Fail, 9, 409, 10.1016/j.ejheart.2006.09.007 Batist, 2001, Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer, J Clin Oncol, 19, 1444, 10.1200/JCO.2001.19.5.1444 Harris, 2002, Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma, Cancer, 94, 25, 10.1002/cncr.10201 Batist, 2006, Anticancer Drugs, 17, 587, 10.1097/00001813-200606000-00014 Brain, 2010, Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptornegative breast carcinoma: a French Geriatric Oncology Group (GERICO) phase II multicentre trial, Crit Rev Oncol/Hematol Pinder, 2007, Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer, J Clin Oncol, 25, 3808, 10.1200/JCO.2006.10.4976 Felker, 2000, Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy, N Engl J Med, 342, 1077, 10.1056/NEJM200004133421502 Swain, 2003, Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials, Cancer, 97, 2869, 10.1002/cncr.11407 Slamon, 2001, Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2, N Engl J Med, 344, 783, 10.1056/NEJM200103153441101 Cortes, 2009, Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study, Clin Cancer Res, 15, 307, 10.1158/1078-0432.CCR-08-1113